Market Research Logo

Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Intercept Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Intercept Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Intercept Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Intercept Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Intercept Pharmaceuticals, Inc.’s pipeline products
Reasons to buy
  • Evaluate Intercept Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Intercept Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Intercept Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Intercept Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intercept Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Intercept Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Intercept Pharmaceuticals, Inc. Snapshot
Intercept Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Intercept Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Intercept Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Intercept Pharmaceuticals, Inc. - Pipeline Products Glance
Intercept Pharmaceuticals, Inc. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Intercept Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Intercept Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Intercept Pharmaceuticals, Inc. - Drug Profiles
obeticholic acid
Product Description
Mechanism of Action
R&D Progress
INT-767
Product Description
Mechanism of Action
R&D Progress
INT-777
Product Description
Mechanism of Action
R&D Progress
Intercept Pharmaceuticals, Inc. - Pipeline Analysis
Intercept Pharmaceuticals, Inc. - Pipeline Products by Target
Intercept Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Intercept Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Intercept Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Intercept Pharmaceuticals, Inc. - Recent Pipeline Updates
Intercept Pharmaceuticals, Inc. - Dormant Projects
Intercept Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Intercept Pharmaceuticals, Inc., Key Information
Intercept Pharmaceuticals, Inc., Key Facts
Intercept Pharmaceuticals, Inc. - Pipeline by Indication, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Intercept Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Intercept Pharmaceuticals, Inc. - Pre-Registration, 2015
Intercept Pharmaceuticals, Inc. - Phase II, 2015
Intercept Pharmaceuticals, Inc. - Phase I, 2015
Intercept Pharmaceuticals, Inc. - Preclinical, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Target, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
Intercept Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
Intercept Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
Intercept Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
Intercept Pharmaceuticals, Inc., Other Locations
List of Figures
Intercept Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Intercept Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
Intercept Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Intercept Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report